Amyloid fibrils associated with Alzheimer's disease
and a wide range of other neurodegenerativediseases have a cross
-sheet structure, where main chain hydrogen bonding occurs between
-str
ands inthe direction of the fibril axis. The surface of the
-sheet has pronounced ridges
and grooves when theindividual
-str
ands have a parallel orientation
and the amino acids are in-register with one another. Herewe show that in A
amyloid fibrils, Met35 packs against Gly33 in the
C-terminus of A
40
and againstGly37 in the
C-terminus of A
42. These packing interactions suggest that the protofilament subunits aredisplaced relative to one another in the A
40
and A
42 fibril structures. We take advantage of thiscorrugated structure to design a new class of inhibitors that prevent fibril formation by placing alternatingglycine
and aromatic residues on one face of a
-str
and. We show that peptide inhibitors based on aGxFxGxF framework disrupt sheet-to-sheet packing
and inhibit the formation of mature A
fibrils asassayed by thioflavin T fluorescence, electron microscopy,
and solid-state NMR spectroscopy. Thealternating large
and small amino acids in the GxFxGxF sequence are complementary to the correspondingamino acids in the IxGxMxG motif found in the
C-terminal sequence of A
40
and A
42. Importantly,the designed peptide inhibitors significantly reduce the toxicity induced by A
42 on cultured rat corticalneurons.